Heparin Solid Formulation: Progress
Reduced overall mass in solid compared to liquid form
Formulation issues have been addressed with innovative formulation approaches
EMISPHERE® delivery agent to drug ratio reduced by fourfold
- Preparing the new oral SNAC/heparin formulation under GMP conditions for clinical testing
- Will combine tablet and capsule attributes to produce a new formulation designed to enhance performance even further
- PROTECT results support a variety of dosage forms and the safety of fixed dose and unmonitored heparin